Bosch Ltd. - Research Center
500530 BOSCHLTD Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Dec' 20 | Sep' 20 | Jun' 20 | Mar' 20 | Dec' 19 | |
|---|---|---|---|---|---|
| Sales | 3,029.64 | 2,479.18 | 991.54 | 2,236.87 | 2,536.64 |
| Operating profit | 358.08 | 288.06 | -102.09 | 341.39 | 320.25 |
| Interest | 6.81 | 1.32 | 1.81 | 4.91 | 2.90 |
| Gross profit | 462.59 | 388.22 | 69.48 | 476.89 | 457.29 |
| EPS (Rs) | 62.99 | -21.97 | -40.85 | 27.51 | 64.54 |
Quarterly
results in details
| Dec' 20 | Sep' 20 | Jun' 20 | Mar' 20 | Dec' 19 | |
|---|---|---|---|---|---|
| Other income | 111.32 | 101.48 | 173.38 | 140.41 | 139.94 |
| Stock adjustment | -163.11 | 134.44 | 82.56 | 584.53 | -211.57 |
| Raw material | 767.14 | 578.03 | 206.71 | 116.99 | 778.58 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 245.46 | 308.33 | 242.68 | 276.30 | 304.93 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,822.07 | 1,170.32 | 561.68 | 917.66 | 1,344.45 |
| Provisions made | - | - | - | - | - |
| Depreciation | 96.93 | 79.60 | 72.83 | 115.80 | 109.84 |
| Taxation | 33.24 | -26.59 | -80.07 | -17.04 | 20.58 |
| Net profit / loss | 185.75 | -64.79 | -120.46 | 81.14 | 190.33 |
| Extra ordinary item | -146.67 | -400.00 | -197.18 | -296.99 | -136.54 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 29.49 | 29.49 | 29.49 | 29.49 | 29.49 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 11.82 | 11.62 | -10.30 | 15.26 | 12.62 |
| GPM (%) | 14.73 | 15.04 | 5.96 | 20.06 | 17.08 |
| NPM (%) | 5.91 | -2.51 | -10.34 | 3.41 | 7.11 |
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis